Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibition

Yuichi Suzuki, Hideyoshi Harashima, Haruno Onuma et al.|Journal of Controlled Release|2020

Cited by 97